Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
Apply
ITI-5000
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step